Official Title
Retrospective Clinical Study of COVID-19 Associated With the Condition and Treatment of Patients With Chinese Psoriasis
Brief Summary

A retrospective analysis based on database was conducted to evaluate the correlationbetween covid-19 infection and the condition and treatment of psoriasis patients.

Detailed Description

Based on the patients registered in the psoriasis patient database of each center, the
patients were followed up by telephone, and the severity of covid-19 infection, the
change of psoriasis condition and the adjustment of treatment methods of psoriasis
patients were collected for retrospective analysis.

Recruiting
Psoriasis Patients
COVID-19
Eligibility Criteria

Inclusion criteria ----

1. No age limit, both male and female are accepted;

2. Psoriasis patients registered in the database;

3. Patients or their families can cooperate to complete the follow-up information
survey (questionnaire, telephone, etc.) independently, and ensure the authenticity
of the data provided.

Exclusion criteria ----

Patients are thought having conditions which are not appropriated for attending this
clinical trial.

Eligibility Gender
All
Eligibility Age
Minimum: N/A ~ Maximum: N/A
Countries
China
Locations

The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing, China

The First Hospital of Lanzhou University
Lanzhou, Gansu, China

Dermatology Hospital of Southern Medical University
Guangzhou, Guangdong, China

The Second Hospital of Jilin University
Changchun, Jilin, China

Dalian Dermatosis Hospital
Dalian, Liaoning, China

Xining First People's Hospital
Xining, Qinghai, China

Xijing Hospital, The Fourth Military Medical University
Xi'an, Shaanxi, China

Shanghai Skin Disease Hospital, Tongji University School of Medicine
Shanghai, Shanghai, China

The University of Hong Kong-Shenzhen Hospital
Shenzhen, Shenzhen, China

West China Hospital, Sichuan University
Chengdu, Sichuan, China

Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital
Tianjin, Tianjin, China

People's Hospital of Xinjiang Uygur Autonomous Region,Xinjiang Key Laboratory of Dermatology Research
Ürümqi, Xinjiang, China

Contacts

GANG WANG, M.D.
13571991903
xjwgang@fmmu.edu.cn

CHEN YU
13571991903

GANG WANG, M.D., Principal Investigator
Xijing Hospital, The Fourth Military Medical University

Gang Wang, MD
NCT Number
Keywords
psoriasis
Covid-19
MeSH Terms
COVID-19
Psoriasis